Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -5.68
- Piotroski Score 4.00
- Grade Overweight
- Symbol (CERS)
- Company Cerus Corporation
- Price $1.73
- Changes Percentage (-1.14%)
- Change -$0.02
- Day Low $1.70
- Day High $1.77
- Year High $2.59
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells donated for transfusion; and INTERCEPT Blood System for Cryoprecipitation that uses its plasma system to produce pathogen reduced cryoprecipitated fibrinogen complex for the treatment and control of bleeding, including massive hemorrhage associated with fibrinogen deficiency, as well as pathogen reduced plasma, cryoprecipitate reduced. It sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. The company was incorporated in 1991 and is headquartered in Concord, California.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 10/30/2024
- Fiscal Year End N/A
- Average Stock Price Target $4.50
- High Stock Price Target $5.00
- Low Stock Price Target $4.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$0.17
- Trailing P/E Ratio -10.47
- Forward P/E Ratio -10.47
- P/E Growth -10.47
- Net Income $-37,489,000
Income Statement
Quarterly
Annual
Latest News of CERS
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Auto theft suspect rams into Irving police cars after leading officers on chase
An investigation is ongoing after a police chase from Irving to Grand Prairie involving an auto theft. The suspect resisted arrest, leading to a confrontation with officers resulting in minor injuries...
By CBS News | 2 days ago -
2 Georgia police officers shot responding to gun store burglary, suspect dead
Two Georgia police officers were injured in a shootout with a suspected gun store burglar. The gunman was killed after exchanging fire with officers at Adventure Outdoors gun store in Smyrna. The inci...
By Fox News | 2 days ago -
Met officers who restrained boy, 14, on ground committed misconduct
The police watchdog found misconduct by officers who restrained a 14-year-old boy for longer than necessary during a stop and search in London. The officers handcuffed the boy after a report of a stol...
By The Guardian | 3 days ago
